A new study shows that COVID-19 infection significantly increases the risk of exacerbation in patients with myasthenia gravis (MG).
Steroid-sparing agents reduce the risk of MG exacerbation post-COVID-19 infection ... the impact of COVID-19 on patients with myasthenia gravis, finding that although most patients did not ...